1.14
-0.13 (-9.92%)
| Previous Close | 1.26 |
| Open | 1.27 |
| Volume | 4,385,498 |
| Avg. Volume (3M) | 5,917,555 |
| Market Cap | 271,726,944 |
| Price / Sales | 15.34 |
| Price / Book | 0.550 |
| 52 Weeks Range | |
| Earnings Date | 30 Apr 2025 - 5 May 2025 |
| Operating Margin (TTM) | -256.39% |
| Diluted EPS (TTM) | -0.340 |
| Quarterly Revenue Growth (YOY) | 30.30% |
| Total Debt/Equity (MRQ) | 14.43% |
| Current Ratio (MRQ) | 8.36 |
| Operating Cash Flow (TTM) | -57.38 M |
| Levered Free Cash Flow (TTM) | -1.13 M |
| Return on Assets (TTM) | -8.69% |
| Return on Equity (TTM) | -15.02% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Specialty Chemicals (US) | Bearish | Bearish |
| Specialty Chemicals (Global) | Bearish | Bearish | |
| Stock | Gevo, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.0 |
| Average | 1.38 |
|
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment. |
|
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Investment Style | Small Growth |
| % Held by Insiders | 4.39% |
| % Held by Institutions | 21.92% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 14.00 (HC Wainwright & Co., 1,133.48%) | Buy |
| Median | 7.58 (567.84%) | |
| Low | 1.15 (UBS, 1.32%) | Hold |
| Average | 7.58 (567.84%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 1.14 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| UBS | 02 Apr 2025 | 1.15 (1.32%) | Hold | 1.13 |
| HC Wainwright & Co. | 28 Mar 2025 | 14.00 (1,133.48%) | Buy | 1.14 |
| 10 Mar 2025 | 14.00 (1,133.48%) | Buy | 1.21 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |